Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose N-acetylcysteine in COPD (crossover pilot study)
2007-003946-13Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetylcysteine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Antwerp University Hospital. Primary endpoints: Effect of delivery treatment on small airways and Effect on inflammation and oxidative stress. Started Aug 2007; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-003946-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003946-13.